RHLD insider Timothy Mahoney boosts stake with 3,268-share buy

Rhea-AI Filing Summary

Resolute Holdings Management, Inc. (RHLD) director Timothy Mahoney reported a purchase of common stock. On 11/18/2025, he acquired 3,268.305 shares of Resolute Holdings common stock in an open-market transaction coded "P" (purchase) at a weighted average price of $152.98 per share. The filing notes that the shares were bought in multiple trades at prices ranging from $152.605 to $153.00. Following this transaction, Mahoney beneficially owns 9,207.305 shares of Resolute Holdings common stock, held directly.

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Mahoney Timothy O.

(Last) (First) (Middle)

C/O RESOLUTE HOLDINGS MANAGEMENT, INC.

445 PARK AVENUE, SUITE 5B

(Street)

NEW YORK NY 10022

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Resolute Holdings Management, Inc. [ RHLD ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
11/18/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	11/18/2025		P		3,268.305	A	$152.98(1)	9,207.305	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. The price reported in Column 4 is the weighted average price. These shares were acquired in multiple transactions at prices ranging from $152.605 to $153.00 inclusive. The reporting person undertakes to provide Resolute Holdings Management, Inc. (the "Issuer"), any securityholder of the Issuer, or the staff of the Securities and Exchange Commission (the "SEC"), upon request, full information regarding the number of shares acquired at each separate price within the ranges set forth in this footnote.

	/s/ Timothy Mahoney, by attorney-in-fact Kurt Schoen	11/20/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.

FAQ

What insider transaction did Resolute Holdings (RHLD) report in this Form 4?

The Form 4 reports that director Timothy Mahoney purchased 3,268.305 shares of Resolute Holdings common stock in an open-market transaction on 11/18/2025.

At what price did the RHLD director buy the shares?

The reported weighted average purchase price was $152.98 per share. The filing explains that the shares were acquired in multiple trades at prices ranging from $152.605 to $153.00, inclusive.

How many Resolute Holdings (RHLD) shares does the insider own after this transaction?

After the reported purchase, director Timothy Mahoney beneficially owns 9,207.305 shares of Resolute Holdings common stock, held directly.

What does transaction code "P" mean in this RHLD Form 4?

Transaction code "P" in the Form 4 indicates an open-market or private purchase of the issuer's equity securities.

Were any derivative securities reported for Resolute Holdings (RHLD) in this filing?

The section for derivative securities is included in the form layout, but this excerpt only provides specific details for a common stock purchase and does not list any derivative transactions.

Who signed the Form 4 for the Resolute Holdings (RHLD) insider transaction?

The Form 4 was signed "/s/ Timothy Mahoney, by attorney-in-fact Kurt Schoen" with a signature date of 11/20/2025.